SCHEMBL2633018

SCHEMBL2633018

COc1ccc2sc(C=O)cc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.62
BACE1 P56817 1/20 0.57
CA2 P00918 1/20 0.54
PDE3B Q13370 1/20 0.51
PDE3A Q14432 1/20 0.51
CLK1 P49759 6/20 0.50
DYRK1A Q13627 4/20 0.50
DYRK1B Q9Y463 1/20 0.50
PRF1 P14222 1/20 0.46
ALDH1A1 P00352 1/20 0.43
TUBB4A P04350 2/20 0.43
TUBB P07437 2/20 0.43
TUBA3C P0DPH7 2/20 0.43
TUBA1B P68363 2/20 0.43
TUBA4A P68366 2/20 0.43
TUBB4B P68371 2/20 0.43
TUBB3 Q13509 2/20 0.43
TUBB2A Q13885 2/20 0.43
TUBB8 Q3ZCM7 2/20 0.43
TUBA3E Q6PEY2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31697962 1.00 CYP2A6 (0.62) CYP2A6BACE1CA2PDE3BPDE3A
SCHEMBL13632617 0.86 CA2 (0.54) CYP2A6BACE1CA2PDE3BPDE3A
SCHEMBL3903263 0.83 CYP2A6 (0.54) CYP2A6BACE1CA2PDE3BPDE3A
SCHEMBL7274175 0.79 BACE1 (0.53) BACE1CA2PDE3BPDE3ACLK1
SCHEMBL7274183 0.79 BACE1 (0.53) BACE1CA2PDE3BPDE3ACLK1
SCHEMBL7275954 0.79 BACE1 (0.53) BACE1CA2PDE3BPDE3ACLK1
SCHEMBL13654182 0.77 CYP2A6 (0.51) CYP2A6BACE1CA2PDE3BPDE3A
SCHEMBL1397680 0.77 CYP2A6 (1.00) CYP2A6DYRK1AALDH1A1
SCHEMBL4580171 0.76 BACE1 (0.67) CYP2A6BACE1CA2PDE3BPDE3A
SCHEMBL7032634 0.75 CYP2A6 (0.51) CYP2A6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113439084-A Duocarmycin analogs 奥克兰联合服务有限公司 2021-09-24 CN disclosed
CN-103992310-B One group replaces benzo heterocyclic amine derivant and preparation method thereof and the related application as IMPDH inhibitor 中国医学科学院医药生物技术研究所 2016-07-06 CN disclosed
US-20120100566-A1 CHEMILUMINESCENT COMPOSITIONS, METHODS, ASSAYS AND KITS FOR OXIDATIVE ENZYMES Life Technologies Corporation (US) 2012-04-26 US disclosed
US-7094798-B1 Inhibitors of checkpoint kinases (Wee1 and Chk1) PFIZER INC (US) 2006-08-22 US disclosed
EP-1501831-A1 INHIBITORS OF CHECKPOINT KINASES (WEE1 AND CHK1) WARNER-LAMBERT COMPANY LLC (US) 2005-02-02 EP disclosed
US-20040147787-A1 Process for oxidation of alcohols MILLER ROSS A (US) 2004-07-29 US disclosed
WO-2003091255-A1 INHIBITORS OF CHECKPOINT KINASES (WEE1 AND CHK1) WARNER-LAMBERT COMPANY LLC (US) 2003-11-06 WO disclosed
WO-2003006435-A1 PROCESS FOR OXIDATION OF ALCOHOLS MERCK & CO., INC. (US) 2003-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147787-A1 Process for oxidation of alcohols TPO, ADH1C, GPX4 CYP2A6 587/4885BACE1 4559/4885CA2 3963/4885
US-20120100566-A1 CHEMILUMINESCENT COMPOSITIONS, METHODS, ASSAYS AND KITS FOR OXIDATIVE ENZYMES CBR1, AOX1, POR CYP2A6 348/4885BACE1 713/4885CA2 1838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.